Torsten Trowe

2.2k total citations · 1 hit paper
17 papers, 1.8k citations indexed

About

Torsten Trowe is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Torsten Trowe has authored 17 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cell Biology and 6 papers in Oncology. Recurrent topics in Torsten Trowe's work include Zebrafish Biomedical Research Applications (7 papers), Immunotherapy and Immune Responses (5 papers) and Axon Guidance and Neuronal Signaling (5 papers). Torsten Trowe is often cited by papers focused on Zebrafish Biomedical Research Applications (7 papers), Immunotherapy and Immune Responses (5 papers) and Axon Guidance and Neuronal Signaling (5 papers). Torsten Trowe collaborates with scholars based in United States, Germany and France. Torsten Trowe's co-authors include Christiane Nüsslein‐Volhard, Michael Brand, Pascal Haffter, Rolf O. Karlstrom, Friedrich Bonhoeffer, Michael Granato, Herwig Baier, Stefan Klostermann, Fredericus J. M. van Eeden and Mary C. Mullins and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Development.

In The Last Decade

Torsten Trowe

17 papers receiving 1.7k citations

Hit Papers

Genes controlling and mediating locomotion behavior of th... 1996 2026 2006 2016 1996 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Torsten Trowe United States 12 1.1k 868 477 229 184 17 1.8k
Akihiro Urasaki Japan 14 1.5k 1.3× 976 1.1× 380 0.8× 377 1.6× 170 0.9× 22 2.3k
Kazuhide Asakawa Japan 26 1.9k 1.6× 1.4k 1.6× 557 1.2× 437 1.9× 232 1.3× 48 2.9k
Kristen M. Kwan United States 14 1.9k 1.6× 877 1.0× 344 0.7× 426 1.9× 161 0.9× 24 2.7k
Juan Ramón Martínez‐Morales Spain 21 1.7k 1.5× 458 0.5× 498 1.0× 409 1.8× 156 0.8× 46 2.0k
Young‐Ki Bae South Korea 23 1.6k 1.4× 835 1.0× 325 0.7× 237 1.0× 306 1.7× 42 2.3k
Hans‐Martin Maischein Germany 28 1.5k 1.3× 1.0k 1.2× 300 0.6× 232 1.0× 137 0.7× 37 2.3k
Paul D. Henion United States 21 1.5k 1.3× 714 0.8× 373 0.8× 308 1.3× 336 1.8× 28 2.2k
Rolf O. Karlstrom United States 28 2.2k 1.9× 875 1.0× 692 1.5× 527 2.3× 338 1.8× 52 3.1k
Alex Nechiporuk United States 24 2.5k 2.1× 971 1.1× 1.1k 2.4× 350 1.5× 106 0.6× 46 3.4k
Heinz‐Georg Belting Switzerland 33 2.4k 2.1× 1.6k 1.8× 326 0.7× 336 1.5× 137 0.7× 53 3.4k

Countries citing papers authored by Torsten Trowe

Since Specialization
Citations

This map shows the geographic impact of Torsten Trowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Trowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Trowe more than expected).

Fields of papers citing papers by Torsten Trowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torsten Trowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Trowe. The network helps show where Torsten Trowe may publish in the future.

Co-authorship network of co-authors of Torsten Trowe

This figure shows the co-authorship network connecting the top 25 collaborators of Torsten Trowe. A scholar is included among the top collaborators of Torsten Trowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torsten Trowe. Torsten Trowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tolcher, Anthony W., Joshua Brody, Nishanthan Rajakumaraswamy, et al.. (2024). Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors. Clinical Cancer Research. 30(14). 2954–2963. 13 indexed citations
2.
Dauki, Anees M., Nishanthan Rajakumaraswamy, Torsten Trowe, et al.. (2024). Pharmacokinetics, pharmacodynamics, and safety of GS‐3583, a FLT3 agonist Fc fusion protein, from single‐ascending‐dose phase I study in healthy participants. Clinical and Translational Science. 17(8). e70011–e70011. 1 indexed citations
3.
Aggarwal, Abhishek, Pamela M. Odorizzi, Jens Brodbeck, et al.. (2022). Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells. JHEP Reports. 5(4). 100664–100664. 17 indexed citations
4.
Tolcher, Anthony W., Joshua Brody, Nishanthan Rajakumaraswamy, et al.. (2022). Phase 1b study of GS-3583, a novel FLT3 agonist Fc fusion protein, in patients with advanced solid tumors.. Journal of Clinical Oncology. 40(16_suppl). 2566–2566. 1 indexed citations
5.
Rajakumaraswamy, Nishanthan, Anees M. Dauki, Michelle Kuhne, et al.. (2021). GS-3583, a novel FLT3 agonist Fc fusion protein, to expand conventional dendritic cells in healthy volunteers.. Journal of Clinical Oncology. 39(15_suppl). 2559–2559. 4 indexed citations
6.
Rajakumaraswamy, Nishanthan, Anees M. Dauki, Michelle Kuhne, et al.. (2021). 380 GS-3583, a novel FLT3 agonist Fc fusion protein, expands conventional dendritic cells in healthy volunteers. Regular and Young Investigator Award Abstracts. A413–A414. 2 indexed citations
7.
Thijssen, Rachel, Jennifer R. Brown, Stacey M. Fernandes, et al.. (2016). Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia. Blood. 128(4). 574–583. 59 indexed citations
8.
Ribrag, Vincent, Julio C. Chávez, Jason Kaplan, et al.. (2016). A Phase 1b, Multi-Center, Open-Label Study of Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-Cell Lymphoma: CC-122-DLBCL-001. Blood. 128(22). 1849–1849. 1 indexed citations
9.
Münster, Pamela N., Amit Mahipal, John Nemunaitis, et al.. (2016). Phase I trial of a dual TOR kinase and DNA-PK inhibitor (CC-115) in advanced solid and hematologic cancers.. Journal of Clinical Oncology. 34(15_suppl). 2505–2505. 17 indexed citations
10.
Trowe, Torsten, Sotiria Boukouvala, Richard E. Cutler, et al.. (2008). EXEL-7647 Inhibits Mutant Forms of ErbB2 Associated with Lapatinib Resistance and Neoplastic Transformation. Clinical Cancer Research. 14(8). 2465–2475. 94 indexed citations
11.
Spoorendonk, Kirsten M., Josi Peterson-Maduro, J. Renn, et al.. (2008). Retinoic acid and Cyp26b1 are critical regulators of osteogenesis in the axial skeleton. Development. 135(22). 3765–3774. 199 indexed citations
12.
Karlstrom, Rolf O., Torsten Trowe, & Friedrich Bonhoeffer. (1997). Genetic analysis of axon guidance and mapping in the zebrafish. Trends in Neurosciences. 20(1). 3–8. 30 indexed citations
13.
Trowe, Torsten, Stefan Klostermann, Herwig Baier, et al.. (1996). Mutations disrupting the ordering and topographic mapping of axons in the retinotectal projection of the zebrafish, Danio rerio. Development. 123(1). 439–450. 133 indexed citations
14.
Karlstrom, Rolf O., Torsten Trowe, Stefan Klostermann, et al.. (1996). Zebrafish mutations affecting retinotectal axon pathfinding. Development. 123(1). 427–438. 246 indexed citations
15.
Granato, Michael, Fredericus J. M. van Eeden, Ursula Schach, et al.. (1996). Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva. Development. 123(1). 399–413. 513 indexed citations breakdown →
16.
Schilling, Thomas F., Tatjana Piotrowski, Heiner Grandel, et al.. (1996). Jaw and branchial arch mutants in zebrafish I: branchial arches. Development. 123(1). 329–344. 280 indexed citations
17.
Baier, Herwig, Stefan Klostermann, Torsten Trowe, et al.. (1996). Genetic dissection of the retinotectal projection. Development. 123(1). 415–425. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026